New combo therapy tested for tough cancers

NCT ID NCT04349267

Completed Disease control Sponsor: Bristol-Myers Squibb Source: ClinicalTrials.gov ↗

First seen Jan 08, 2026 · Last updated May 15, 2026 · Updated 21 times

Summary

This study tested a new drug called BMS-986315, either alone or combined with other cancer drugs (nivolumab or cetuximab), in 44 people with advanced solid tumors like head and neck, lung, or kidney cancer. The main goals were to check safety and find the right dose. This is an early-stage trial, so it focuses on side effects and tumor shrinkage, not a cure.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Local Institution

Mexico City, Mexico City, 06100, Mexico
Local Institution - 0001

Germantown, Tennessee, 38138, United States
Local Institution - 0004

Toronto, Ontario, M5G 2M9, Canada
Local Institution - 0005

Montreal, Quebec, H2X 3E4, Canada
Local Institution - 0011

Vancouver, British Columbia, V5Z 4E6, Canada
Local Institution - 0013

Ottawa, K1H 8L6, Canada
Local Institution - 0014

Edmonton, Alberta, T6X 1E8, Canada
Local Institution - 0028

Sioux Falls, South Dakota, 57104, United States

Conditions

Explore the condition pages connected to this study.

ADVANCED SOLID TUMOR